All Stories

  1. Risk factors for late recurrence after 5-year adjuvant endocrine therapy

    Article • OncoTargets and Therapy, October 2017, Dove Medical Press

    Junming Xu, Ye Wang, Junyi Wu, Jun Qin, Min Wang, Tao jin